Home » Topics » Regulatory » Patents

Patents
RSS

Novel tachykinin antagonists from Glaxo Wellcome

Nov. 8, 1996

NK1 antagonists described by Merck & Co.

Nov. 8, 1996

Growth hormone secretion stimulants claimed by Merck & Co.

Nov. 1, 1996

Lilly reports long-acting, soluble insulin analogues

Nov. 1, 1996

Hypoglycemic agents disclosed by Yamanouchi

Nov. 1, 1996

Boehringer Ingelheim claims 5-HT4 antagonists for various indications

Nov. 1, 1996

Novel antiulcer agents reported by Arax

Nov. 1, 1996

Merck & Co. describes CCK/gastrin antagonists

Nov. 1, 1996

Terumo discloses agents with activity against H. pylori

Nov. 1, 1996

Factor Xa/thrombin inhibitors from Roche

Nov. 1, 1996

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...